embolization of the middle meningeal artery
Sponsors
Dartmouth-Hitchcock Medical Center, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), University of Manitoba, Ospedale Policlinico San Martino, Juan M. Ramos Acevedo
Conditions
Chronic Subdural HematomaChronic Subdural HematomasSubdural HematomaSubdural Hematoma, Chronic
Unknown Phase
Dartmouth Middle Meningeal Embolization Trial (DaMMET)
CompletedNCT04270955
Start: 2020-03-11End: 2024-01-11Updated: 2024-02-22
Embolization of Middle Meningeal Artery in Chronic Subdural Hematoma
RecruitingNCT04511572
Start: 2020-12-10End: 2025-10-01Target: 170Updated: 2024-07-31
Management of CSDH With or Without EMMA- a Randomized Control Trial
Active, not recruitingNCT04750200
Start: 2021-08-01End: 2026-08-31Updated: 2026-04-28
Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can)
RecruitingNCT04923984
Start: 2021-05-01End: 2029-12-31Target: 1000Updated: 2026-02-03
Endovascular vs Conservative Treatment in Patients With Chronic Subdural Hematomas and Mild Symptoms
Not yet recruitingNCT06274580
Start: 2024-03-01End: 2026-03-01Target: 300Updated: 2024-02-23
Puerto Rico Embolization of the Middle Meningeal Artery for the Treatment of Chronic Subdural Hematoma Trial (PREMMA)
Not yet recruitingNCT06466733
Start: 2025-05-31End: 2032-07-31Target: 658Updated: 2025-05-07